Last updated: August 30, 2026

Application No. 18/949,084

THERAPEUTIC COMPOUNDS

Non-Final OA

Filed

Nov 15, 2024

Priority

Nov 17, 2023 — EU 23210687.2

Examiner

SHAMEEM, GOLAM M

Art Unit

Tech Center

Assignee

Sanofi S.A.

OA Round

1 (Non-Final)

Interview Optional

— +16.0% interview lift. Examiner has a relatively high allowance rate (87%); +16.0% interview lift. A written response may suffice.

Based on 891 resolved cases, 2023–2026

Examiner Intelligence

SHAMEEM, GOLAM M View full profile →

Grants 87% — above average

Career Allowance Rate

772 granted / 891 resolved

+26.6% vs TC avg

Strong +16% interview lift

Without

With

+16.0%

Interview Lift

resolved cases with interview

Fast prosecutor

1y 10m

Avg Prosecution

49 currently pending

Career history

909

Total Applications

across all art units

Statute-Specific Performance

§101

2.8%

-37.2% vs TC avg

§103

5.1%

-34.9% vs TC avg

§102

18.2%

-21.8% vs TC avg

§112

23.5%

-16.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 891 resolved cases

Prosecution Timeline

Nov 15, 2024

Application Filed

Aug 18, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/799,249

Patent 12715850

LOW TOXICITY NMP SUBSTITUTES AND USES THEREOF

4y 0m to grant Granted Aug 25, 2026

18/694,691

Patent 12715869

Modulators of CAMKK2 as Ligand Directed Degraders

2y 5m to grant Granted Aug 25, 2026

17/907,711

Patent 12709622

CONJUGATES FOR SELECTIVE RESPONSIVENESS TO VICINAL DIOLS

3y 10m to grant Granted Aug 18, 2026

18/785,279

Patent 12709605

NOVEL PYRIDINE AND PYRAZINE COMPOUNDS AS INHIBITORS OF CANNABINOID RECEPTOR 2

2y 0m to grant Granted Aug 18, 2026

17/625,704

Patent 12703679

SULFONE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS

4y 7m to grant Granted Aug 11, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

87%

Grant Probability

99%

With Interview (+16.0%)

1y 10m (~1m remaining)

Median Time to Grant

Low

PTA Risk

Based on 891 resolved cases by this examiner. Grant probability derived from career allowance rate.